Furthermore, the possible penetration of tissue plasminogen activator through the retina and the potential risk of complications, including rebleeding, vitreous hemorrhage, and retinal toxicity, were concerning [4,17–21]. The gene discussed is PLAT; the disease is vitreous hemorrhage.